Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

(2021) Michael Dougan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

(2021) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021

(2021) Lyudmyla Kompaniyets et al.   Preventing Chronic Disease

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

(2021) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021

(2021) Heather M. Scobie et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

(2021) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

(2021) Peter J. Embi et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

COVID-19 and Racial/Ethnic Disparities

(2020) Monica Webb Hooper et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness — United States, 2018

(2020) Hilda Razzaghi et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT